You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 856 Preliminary review of Diabetes Mellitus incidence in patients treated with immune checkpoint inhibitors (ICI) therapy – Roswell Park Comprehensive Cancer Center (RPCCC) experience

Article metrics

Article menu

Download PDFPDF

Late-breaking abstracts
Immunotherapy toxicities
856 Preliminary review of Diabetes Mellitus incidence in patients treated with immune checkpoint inhibitors (ICI) therapy – Roswell Park Comprehensive Cancer Center (RPCCC) experience

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 202062011
Dec 202058010
Jan 2021604
Feb 2021802
Mar 20214508
Apr 20212406
May 2021404
Jun 2021003
Jul 2021003
Aug 2021001
Sep 2021005
Oct 202124023
Nov 202137018
Dec 20211204
Jan 20224804
Feb 20223405
Mar 20222407
Apr 20224405
May 20222600
Jun 20224400
Jul 20223200
Aug 20223404
Sep 20224000
Oct 20223200
Nov 20221603
Dec 20223401
Jan 20233800
Feb 20232600
Mar 20234803
Apr 20231202
May 20231803
Jun 20231001
Jul 20231402
Aug 20232200
Sep 2023604
Oct 20231602
Nov 20231802
Dec 20232002
Jan 20241200
Feb 20241202
Mar 20241602
Apr 20241800
May 20241600
Jun 20242508
Jul 20243604
Aug 20242503
Sep 20242205
Oct 20243400
Nov 20241201
Dec 20241404
Jan 20253004
Feb 2025600
Mar 2025001
Apr 2025006
May 2025003
Jun 2025104
Total12150199